TY  - GEN
AU  - Holst,Jens Juul
TI  - Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors
SN  - 1744-7623
PY  - 2005///0721
KW  - Adenosine Deaminase
KW  - physiology
KW  - Adenosine Deaminase Inhibitors
KW  - Afferent Pathways
KW  - Animals
KW  - Appetite
KW  - drug effects
KW  - Diabetes Mellitus, Experimental
KW  - drug therapy
KW  - Diabetes Mellitus, Type 2
KW  - Dipeptidyl Peptidase 4
KW  - Drug Therapy, Combination
KW  - Exenatide
KW  - Glucagon
KW  - agonists
KW  - Glucagon-Like Peptide 1
KW  - Glucagon-Like Peptide-1 Receptor
KW  - Glycoproteins
KW  - antagonists & inhibitors
KW  - Humans
KW  - Hypoglycemic Agents
KW  - administration & dosage
KW  - Hypothalamus
KW  - Insulin
KW  - biosynthesis
KW  - Insulin Secretion
KW  - Intestinal Mucosa
KW  - innervation
KW  - Islets of Langerhans
KW  - Liraglutide
KW  - Lizards
KW  - Maleimides
KW  - therapeutic use
KW  - Mice
KW  - Mice, Knockout
KW  - Mice, Obese
KW  - Peptide Fragments
KW  - Peptides
KW  - pharmacology
KW  - Proglucagon
KW  - Protein Precursors
KW  - Rats
KW  - Rats, Zucker
KW  - Receptors, Glucagon
KW  - Venoms
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1517/eoed.9.1.155.32952
ER  -